Image credits: Artur Tumasjan en Unsplash
/
Weekly Roundups

One Week Left for Mexico Health Summit ECHO

By Miriam Bello | Thu, 08/25/2022 - 10:00

This week, vaccine shortages and other controversies took the spotlight. In international news, recent findings on the long-term impact of COVID-19 are causing concern among global health experts.

Here is the week in health!

Mexico Health Summit is Around the Corner!

Mexico Health Summit 2022 ECHO is next week! Be sure to join us on Aug. 31 and Sept. 1 to learn from the most relevant decision-makers of the industry. This is the first time the event will be hybrid, allowing you to enjoy the best of in-person and virtual interactions. Here is more information on the event.

Pharmacy Adjacent Medical Offices Cause Controversy

Pharmacy Adjacent Medical Offices (PAMOs) have become a staple across Mexico, but Deputy Minister of Health Hugo López-Gatell said that these spaces do not offer real solutions to many health problems, including chronic diseases. López-Gatell said that PAMOs do not operate under adequate labor standards and can even violate worker’s rights. He also stated that the use of these services can put the patients in danger.

Vaccine Shortages for Children

Parents decried the shortage of vaccines for babies and small children in the Mexico City metropolitan area, including vaccines for tuberculosis, measles and rubella, reported Animal Politico. According to the Mexican Social Security Institute (IMSS), the shortages were caused by a supplier delay. The medical units are expected to have the necessary vaccines to immunize children by the end of August.

COVID-19 Infection Linked to Brain Disorders

A study published in the journal Lancet Psychiatry found that those who had a COVID-19 infection face an increased risk of neurological and psychiatric conditions such as mental confusion, psychosis, seizures and dementia for up to two years after infection. The results suggest that cases of neurological problems related to COVID-19 could continue appearing even after the pandemic subsides.

US Inflation Reduction Act Aims to Lower Drug Prices

The Inflation Reduction Act of 2022, recently approved by the US government, introduces several provisions to improve healthcare services, including potential changes to prescription drug prices. Besides targeting healthcare, the recently approved Inflation Act also aims to lower the US’s deficit and tackle the climate crisis.

Experts of the Week!

Miriam Bello Miriam Bello Senior Journalist and Industry Analyst